ADB-Butinaca Powder

ADB-Butinaca Powder, a synthetic cannabinoid, is a widely recognized chemical compound in research-based applications within the field of pharmacology and neuroscience. It belongs to the indazole-3-carboxamide family and is often studied for its interaction with cannabinoid receptors (CB1 and CB2). Structurally, ADB-Butinaca’s chemical notation is N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-butylphenyl)-1H-indazole-3-carboxamide, with a molecular formula of C20H28N4O2 and a molecular weight of approximately 356.47 g/mol.

This compound is engineered for analytical purposes and serves as a crucial tool for researchers aiming to dissect the mechanisms of cannabinoid receptor agonists. ADB-Butinaca is intended for laboratory research only and is not designed for human or animal consumption.

Chemical Properties

• Chemical Name: ADB-Butinaca
• Formula: C20H28N4O2
• Molecular Weight: 356.47 g/mol
• IUPAC Name: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-butylphenyl)-1H-indazole-3-carboxamide
• Class: Synthetic Cannabinoid (Indazole-3-Carboxamide Derivative)

The compound exhibits high affinity for cannabinoid receptors, particularly CB1, which predominantly exists in the central nervous system, and CB2, which appears largely in peripheral tissues. Its potency makes it a candidate for studying the pharmacodynamics and pharmacokinetics of synthetic cannabinoids, as well as their potential applications in therapeutic settings.

Applications in Research

ADB-Butinaca Powder is widely employed in biochemical and pharmacological research to assess the efficacy, safety, and cellular implications of synthetic cannabinoids. Key areas of research where it is frequently applied include:

• Cannabinoid Receptor Binding Studies: This compound allows researchers to evaluate how synthetic cannabinoids interact with CB1 and CB2 receptors, shedding light on binding affinity and selectivity. These studies help distinguish pharmacological activity profiles across various compounds.
• Pharmacological Screening: ADB-Butinaca serves as a critical tool in high-throughput screening studies aimed at identifying CNS modulators. Its ability to mimic natural endocannabinoids makes it suitable for exploring potential drug candidates for conditions such as chronic pain, inflammation, neurodegenerative diseases, and mood disorders.
• Toxicological Analysis: Synthetic cannabinoids like ADB-Butinaca are increasingly studied to understand adverse effects linked to their recreational misuse. These studies provide insight into dosage thresholds, metabolic pathways, and long-term health impacts.
• Forensic Science Applications: ADB-Butinaca is a notable compound for forensic toxicology research, aiding in the identification of synthetic cannabinoids within biological samples. Its presence on both gray and black markets makes it a focus area for analysts monitoring trends in recreational compound misuse.

Form and Appearance

ADB-Butinaca Powder is a fine, crystalline solid that typically appears off-white to light brown in coloration. It is highly soluble in solvents such as ethanol and dimethyl sulfoxide (DMSO) and demonstrates stability under normal laboratory storage conditions.

Storage and Stability

Proper handling and storage are essential to maintaining the integrity of ADB-Butinaca Powder. Recommended storage conditions include keeping the powder in a cool, dry place, away from direct sunlight and moisture. The compound should be stored in a tightly sealed container to minimize degradation. Typically, storage temperatures of -20°C to -10°C are advised, with adequate labeling to ensure regulatory compliance and safety. Shelf life varies depending on exposure to environmental factors, but the compound generally remains potent for up to 2 years under ideal storage conditions.

Safety Information

ADB-Butinaca Powder is strictly intended for laboratory research and should not be used for human or animal consumption. Adequate precautions, including the use of personal protective equipment (PPE), such as gloves, goggles, and lab coats, are necessary to ensure user safety during handling. Researchers must comply with all Material Safety Data Sheet (MSDS) guidelines and local regulations concerning the handling, disposal, and transportation of research chemicals.

Key safety details include:

• Hazard Codes: H302 (Harmful if swallowed), H315 (Causes skin irritation), H319 (Causes serious eye irritation)
• Precautionary Statements: Use proper ventilation, avoid direct contact, and handle only in well-equipped laboratory settings. Dispose of waste in accordance with local environmental guidelines.

Regulatory Status

ADB-Butinaca is subject to varying legal restrictions depending on jurisdiction. Researchers should verify its legal status in their respective regions before purchasing or using the compound. Notably, synthetic cannabinoids in this classification are often regulated due to their potential misuse and psychoactive properties.

Advantages of High-Purity ADB-Butinaca Powder

• Consistency: Laboratory-grade ADB-Butinaca ensures uniformity in experimentation, minimizing data variability and increasing reliability.
• Purity: High-purity formulations (>98%) reduce the risk of contaminants, providing clearer results in scientific studies.
• Scalability: Available in various quantities to accommodate both small-scale exploratory studies and large-scale research projects.

Disclaimer

This product is sold for research and development purposes only. It is not approved for medical, cosmetic, or any form of therapeutic use. Researchers are responsible for adhering to all applicable laws and conducting appropriate risk assessments before handling.

For additional inquiries or bulk orders, consult the supplier’s technical support team or review the accompanying product certificate of analysis.